Adeniyi AA, Olamiju PO, Adeniyi OA, Adetunji SO, Odiabo GN and Kemiki OA. 2022. Detection of HBV DNA among HBsAg Negative Patients. Virol Immunol j;DOI:10.23880/vij-16000294.
Allain JP, Candotti D, Soldan K, Sarkodie F, Phelps B, Giachetti C, Shyamala V, Yeboah F, Anokwa M, Owusu-Ofori S, Oparesem O. 2003. The risk of hepatitis B virus infection by transfusion in Kumasi, Ghana. Blood 101: 2419-2425.
Allain JP. 2004. Occult hepatitis B virus infection. Transfus Clin Biol 11:18–25.
Almeida-Neto C, Strauss E, Sabino EC, Sucupira MC, Chamone DA. 2001. Significance of isolated hepatitis B core antibody in blood donors from Sao Paulo. Rev Inst Med Trop Sao Paulo 43: 203-208.
Ando K, Guidotti LG, Wirth S, Ishikawa T, Missale G, Moriyama T. 1994. Class-1 restricted cytotoxic T- lymphocytes are directed cytopathic for their target cells in-vivo. J Immuno 152(7): 3245-3253.
Baginski I, Chemin I, Hantz O, Pichoud C, Jullien AM, Chevre JC. 1992. Transmission of serologically silent hepatitis B virus along with hepatitis C virus in two cases of post-transfussion hepatitis. Transfussion 32: 215-20.
Berasain C, Betes M, Panizo A, Ruiz J, Herrero JI, Civeira MP. 2000. Pathological and virological findings in patients with persistent hypertransaminasaemia of unknown aetiology. Gut 47: 429-35.
Blumberg BS, Alter HJ, Visnich S. 1965. A “New” Antigen in Leukemia Sera. The Journal of the American Medical Association 191: 541–546.
Bouchard MJ, Schneider RJ. 2004. The enigmatic X gene of hepatitis B virus. J Virol 78:12725–12734.
Brechot C, Thiers V, Kremsdorf D, Nalpas B, Pol S, Paterlini-Brechot P . 2001. Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: Clinically significant or purely "occult"? Hepatology 34: 194–203.
Bruss V, Ganem D. 1991. The role of envelope proteins in hepatitis B virus assembly. Proc Natl Acad Sci 88: 1059-63.
Cabrerizo M, Bartolome J, Caramelo C, Barril G, Carreno V. 2000. Molecular analysis of hepatitis B virus DNA in serum and peripheral blood mononuclear cells from hepatitis B surface antigen-negative cases. Hepatology 32: 116–123.
Carman W.F., Molecular varients of hepatitis B virus. Clin Lab Med 1996; 16: 407-428.
Chemin I, Trepo C. 2005. Clinical Impact of occult HBV infection. J Clinical Virol 34:
Chen MT, Billaud JN, Sallberg M, Guidotti LG, Chisari FV, Jones J, Hughes J, Milich DR. 2004. A function of the hepatitis B virus precore protein is to regulate the immune response to the core antigen. Proceedings of the National Academy of Sciences of the United States of America 101:14913–14918.
Chu CJ, Hussain M, Lok AS. 2002. Quantitative serum HBV DNA levels during different stages of chronic hepatitis B infection. Hepatology 36: 1408–1415.
Comanor L, Holland P. 2006. Hepatitis B virus blood screening: unfinished agendas. Vox Sang 91: 1-12.
Croagh CM, Desmond PV, Bell SJ. 2015. Genotypes and viral varients in chronic hepatitis B: A review of epidemiology and clinical relevance. World J. Hepatol 7(3): 289-303.
Cross JC, Wen P, Rutter W. 1993. Transactivation by hepatitis B virus X protein is promiscuous and dependent on mitogen-activated cellular serine/threonine kinases. Proc Natl Acad Sci U S A 90:8078–8082.
Das A, Hoare M, Davies N. 2008. Functional skewing of the global CD8 T cell population in chronic hepatitis B virus infection. Journal of Experimental Medicine 205(9): 2111–2124.
Datta S. 2008. An overview of moleculer epidemiology of Hepatitis B virus (HBV) in India. Virology Journal 5: 156.
de Franchis R, Hadengue A, Lau G, Lavanchy D, Lok A. 2003. EASL International Consensus Conference on Hepatitis B. 13-14 September, 2002 Geneva, Switzerland. Consensus statement (long version). J Hepatol 39 Suppl 1: S3-25.
de Franchis R., Meucci G, Vecchi M. 1993. The natural history of asymptomatic hepatitis B surface antigen carriers. Ann Intern Med 118: 191-4.
Dindoost P, Jazayeri SM, Karimzadeh H, Saberfar E, Miri SM. (2012) HBsAg variants: common escape issues. Jundishapur J Microbiol 5(4): 521-527.
Ejele OA and Ojule AC. 2004. The prevalence of hepatitis B surface antigen (HBsAg) among prospective blood donors in Port-Harcourt, Nigeria. Niger J Med 13(4): 336-8.
Enders GH, Ganem D, Varmus H. 1985. Mapping the major transcripts of ground squirrel hepatitis virus: the presumptive template for reversetranscriptase is terminally redundant. Cell 42:297–308.
Fasola FA, Kotila TR, Akinyemi JO. 2008. Trends in transfusion-transmitted viral infections from 2001 - 2006 in Ibadan, Nigeria. Intervirology 51: 427-431.
Fauquet CM, Mayo MA, Maniloff J, Desselberger U, Ball LA. 2005. Virus Taxonomy: Eighth Report of the International Committee of Taxonomy of Viruses. Hepadnaviridae. San Diego, CA: Elsevier Academic Press 2005:373–384.
Feitelson M, Lega L, Guo J, Resti M, Rossi ME, Azzari C. 1994. Pathogenesis of post tranfussion viral hepatitis in children with betathalassemia. Hepatology 19: 558-68.
Ganem D, Prince AM. 2004. Hepatitis B virus infection Natural history and clinical consequences. New England Journal Medicine 350: 1118–1129.
Ganem D, Schneider R.J. 2001. Hepadnaviridae: the viruses and their replication. In: Fields virology 4th edition. Edited by: Knipe DM; Howley PM. Philadelphia: Lippincott Williams & Wilkins 2923 - 2969.
Gerlich W, Robinson WS. 1980. Hepatitis B virus contains protein attached to the 5′ end of its complete strand. Cell 21:801–811.
Giovanni Raimondo, Gaia Caccamo, Roberto Filomia, and Teresa Pollicino. Occult HBV infection. Semin Immunopathol. 2013 Jan; 35(1): 39–52.
Gitlin N. 1997. Hepatitis B: diagnosis, prevention, and treatment. Clin Chem 43(8B):1500–1506.
Goldstein ST, Zhou F, Hadler SC, Bell BP, Mast EE, Margolis HS. 2005. A mathematical model to estimate global hepatitis B disease burden and vaccination impact. Int J Epidemiol 34(6): 1329.
Grob P, Jilg W, Bornhak H, Gerken G, Gerlich W, Günther S, Hess G, Hüdig H, Kitchen A, Margolis H. 2000. Serological pattern “anti-HBc alone”: report on a workshop. J Med Virol. 62:450–455
Guidotti LG, McClary H, Loudis JM, Chisari FV. 2000. Nitric oxide inhibits hepatitis B virus replication in the livers of transgenic mice. J Exp Med 191(7): 1247-1252.
Guo H, Mason WS, Aldrich CE, Saputelli JR, Miller DS, Jilbert AR and Newbold JE. 2005. Identification and classification of avihepadnaviruses isolated from exotic anseriformes maintained in captivity. Journal of Virology 79:2729–2742.
Hennig H, Puchta I, Luhm J, Schlenke P, Goerg S, Kirchner H. 2002. Frequency and load of hepatitis B virus DNA in first-time blood donors with antibodies to hepatitis B core antigen. Blood 100: 2637-41.
Hollinger FB, Liang TJ. 2001. Hepatitis B virus. In: Fields Virology 4th edition. Edited by: Knipe D.M., Howley P.M. Philadelphia: Lippincott Williams & Wilkins 2001: 2971-3036.
Hoofnagle JH. 1981. Serologic markers of hepatitis B virus infection. Annu Rev Med 32:111.
Hou J, Liu Z, Gu F. 2005. Epidemiology and Prevention of Hepatitis B Virus Infection. International Journal of Medical Sciences 2.1: 50–57.
Howard CR. 1986. "The biology of hepadnaviruses". J. Gen. Virol. 67 (7): 1215–35.
Hu Z, Zhang Z, Kim JW, Huang Y, Liang TJ. 2006. Altered proteolysis and global gene expression in hepatitis B virus X transgenic mouse liver. J Virol 80:1405–1413.
Jilbert AR Wu TT, England JM. 1992. Rapid resolution of duck hepatitis B virus infections occurs after massive hepatocellular involvement. Journal of Virology 66: 1377–1388.
Kajino K, Jilbert AR, Saputelli J. 1994. Woodchuck hepatitis virus infections: very rapid recovery after a prolonged viremia and infection of virtually every hepatocyte. Journal of Virology 68: 5792–5803.
Kakimi K, Guidotti LG, Lane TE, Chisari FV. 2001. Cutting edge: Inhibition of hepatitis B virus replication by activated NK cells does not require inflammatory cell recruitment to the liver. J Immonol 167(12):6701-6705.
Kleimman SH; Busch MP. 2001. HBV amplified and back in the blood safety sportlight. Transfusion 41: 1081-5.
Krugman S, Giles JP, Hammond J. Infectious hepatitis: evidence for two distinctive clinical, epidemiological, and immunological types of infection. JAMA 1967;200: 365-73.
Kwak MS, Kim YJ. 2014. Occult hepatitis B virus infection. World J Hepatol. 6(12): 860–869.
Lavenchy D. 2004. Hepatitis B virus epidermiology, disease burden, treatment and current and emerging prevention and control measures: a review. J Viral Hepat 11: 97-107.
Lee WM. 1997. Hepatitis B virus infection. N Engl J Med 337:1733–1745.
Lemon SM, Layden TJ, Seeff L. 2000. The 20th United States- Japan Joint Hepatitis Panel Meeting. Hepatology 31(3): 800–806.
Liang TJ. 2009. Hepatitis B: The Virus and Disease. Hepatology 49(5 Suppl): S13–S21.
Lin B, Anderson DA. 2000. "A vestigial X open reading frame in duck hepatitis B virus". Intervirology. 43 (3): 185–90.
Loeb DL, Hirsch RC, Ganem D. 1991. Sequence independent RNA cleavages generate the primers for plus strand DNA synthesis in hepatitis B viruses: implications for other reverse transcribing elements. The EMBO Journal 10: 3533–3540.
Lok AS, McMahon BJ. 2001. Chronic hepatitis B. Hepatology 34:1225-41.
Loriot MA, Marcellin P, Bismuth E, Martinot-Peignoux M, Boyer N, Degott C, Erlinger S, Benhamou JP. 1992. Demonstration of hepatitis B virus DNA by polymerase chain reaction in the serum and the liver after spontaneous or therapeutically induced HBeAg to anti-HBe or HBsAg to anti-HBs seroconversion in patients with chronic hepatitis B. Hepatology 15:32–36.
Magnius LO, Norder H. 1995. Subtypes, genotypes and molecular epidemiology of the hepatitis B virus as reflected by sequence variability of the S-gene. Intervirology; 38(1-2): 24-34.
Mahoney FJ. 1999. Update on diagnosis, management, and prevention of hepatitis B virus infection. Clin Microbiol Rev 12(2): 351–366.
Margolis HS, Alter MJ, Hadler SC. 1991. Hepatitis B: evolving epidemiology and implications for control. Semin Liver Dis 11: 84-92.
Maria LG, Conrado MF, Jose LL, Ingrid B. 2015. Prevalence of occult hepatitis B virus infection. World J Gastroenterol 16:12.
Martin P, Friedman LS, Dienstag JL. 1993. Diagnostic approach in viral hepatitis: scientific basis and clinical management. Edinburgh: Churchill Living-stone P. 393-408.
Mason WS, Jilbert AR Summers J. 2005. Clonal expansion of hepatocytes during chronic woodchuck hepatitis virus infection. Proceedings of the National Academy of Sciences of the United States of America 102: 1139–1144.
McGlynn K A, Tsao L, Hsing AW. 2001. International trends and patterns of primary liver cancer. Int J Cancer 94(2): 290–296.
Mel K, Gail M, and Martin P. 2005. The Laboratory Diagnosis of Hepatitis B Virus. Canadian J inf. Disease and Med Mic 16(2):65-72.
Meuleman, P., Libbrecht, L. and Wieland, S. (2006). Immune suppression uncovers endogenous cytopathic effects of the hepatitis B virus. Journal of Virology 80: 2797–2807.
Michalak TI, Pasquinelli C, Guilhot S, Chisari FV. 1994. Hepatitis B virus persistence after recovery from acute viral hepatitis. J Clin Invest 93: 230-239.
Milich D, Liang TJ. 2003. Exploring the biological basis of hepatitis B e antigen in hepatitis B virus infection. Hepatology 38:1075–1086.
Mosley JW, Stevens CE, Aach RD, Hollinger FB, Mimms L, Solomon LR. 1995. Donor screening for antibody to hepatitis B core antigen and hepatitis B virus infection in transfusion recipients. Transfussion 35: 5-12.
Norborg U, Gusdal A, Horal P, Lindh M. 2000. Levels of viremia in subjects with serological markers of past or chronic hepatitis B virus infection. Scand J Infect Dis 32: 249-252.
Norder H, Courouce´ A-M, Magnius LO. 1994. Complete genomes, phylogenetic relatedness, and structural proteins of six strains of the hepatitis B virus, four of which represent two new genotypes. Virology 198: 489–503.
Nwokedi EO, Odimayo MS, Emokpae AM, Yahaya IA, Sadiq MN, Okwori EE. 2011. Seroprevalence of hepatitis B surface antigen among patients attending Aminu Kano Teaching Hospital, Kano. Niger J Med 20(2): 213-5.
Odemuyiwa SO, Mulders MN, Oyedele OI, Ola SO, Odaibo GN. 2001. Phylogenetic analysis of new hepatitis B virus isolates from Nigeria supports endemicity of genotype E in West Africa. J Med Virol 65: 463-469.
Okamoto H, Tsuda F, Sakugawa H, Sastrosoewignjo RI, Imai M, Miyakawa Y, Mayumi M. 1998. Typing hepatitis B virus by homology in nucleotide sequence: comparison of surface antigen subtypes. J Gen Virol 69: 2575 - 2583.
Olinger CM, Jutavijittum P, Hübschen JM, Yousukh A, Samountry B, Thammavong T, Toriyama K, Muller CP. 2008. "Possible new hepatitis B virus genotype, southeast Asia". Emerging Infectious Diseases. 14 (11): 1777–80
Opaleye OO, Tong HV, Bui Tien S, Fagbami AH, Adekanle O, Ojurongbe O. 2015. Occult Hepatitis B Virus Infection in Nigerian Blood Donors and Hepatitis B Virus Transmission Risks. PLoS ONE 10(7): e0131912.
Prince AM, Fuji H, Gershon RK. 1964. Immunohistochemical studies on the etiology of anicteric hepatitis in Korea. Am J Hyg 79:365-81.
Prince AM, Lee DH, Brotman B. 2001. Infectivity of blood from PCR-positive, HBsAg-negative, anti-HBs-positive casesof resolved hepatitis B infection. Transfussion 41: 329-32.
Raimondo G, Allain JP, Brunetto MR, Buendia MA, Chen DS, Colombo M. (2008). Statements from the Taormina expert meeting on occult hepatitis B virus infection. J Hepatol 49: 652–657.
Rehermann B, Ferrari C, Pasquinelli C, Chisari FV. 1996. The hepatitis B virus persists for decades after patients’ recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response. Nat Med 2: 1104-1108.
Ribeiro RM, Lo A, Perelson AS. 2002. Dynamics of hepatitis B virus infection. Microbes Infect 4: 829-35.
Robinson WS. 1995. Hepatitis B virus and Hepatitis D virus. In: Mandell G.L., Bennett J.E., Dolin R., eds. Principles and Practice of Infectious Disease, 4th Ed. New York, Churchill Livingstone 1406-1439.
Schaefer S. Hepatitis B virus: Significance of genotypes. J Viral Hepat 2005. 12: 111- 124.
Schildgen O, Helm M, Gerlich W. 2006. Non-response to adefovir: host or virus dependent? J Clin Virol 37: 327-8.
Scott R.M, Snitbhan R, Bancroft W.H, Alter H.J, Tingpalapong M. 1980. Experimental transmission of hepatitis B virus by semen and saliva. J Infect Dis 142: 67-71.
Seager C and Mason W. 2000. Hepatitis B virus Biology. Microbiol. Mol biol rev Vol 64: No 1. p.51- 68.
Seeger C., Zoulim F and Mason W. HEPADNAVIRIDAE. In: Fields Virology 5th edition. Edited by: Knipe D.M, Howley P.M. Philadelphia: Lippincott Williams & Wilkins; 2007: 2979-3013
Servoss J.C., Freidman L.S., Dienstag J.L. Diagnostic approach to viral hepatitis. In:
Servoss JC, Freidman LS. 2006. Serologic and Molecular diagnosis of hepatitis B virus. Infect Dis Clin N Am 20: 47-61.
Shiota G, Oyama K, Udagawa A, Tanaka K, Nomi T, Kitamuri A. 2000. Occult hepatitis B virus infection in HBs antigen-negative hepatocellular carcinoma in a Japanese population. J Med Virol 62: 151-8.
Stevens CE, Beasley RP, Tsui J, Lee WC. 1975. Vertical transmission of hepatitis B antigen in Taiwan. N Engl J Med 292: 771-4.
Stuyver L, De Gendt S, Van Geyt C, Zoulim F, Fried M, Schinazi RF, Rossau R. 2000. A new genotype of hepatitis B virus: Complete genome and phylogenetic relatedness. J. Gen Virol 81: 67- 74.
Sum SS, Wong DK, Yuen JC. 2005. Comparison of the COBAS Taq Man HBV test with the COBAS Amplicor monitor test for measurement of hepatitis B virus DNA in serum. J Med Virol 77: 486-90.
Summers J, Jilbert AR., Yang W. 2003. Hepatocyte turnover during resolution of a transient hepadnaviral infection. Proceedings of the National Academy of Sciences of the United States of America 100: 11652–11659.
Tang JR, Hsu HY, Lin HH, Ni YH, Chang MH. 1998. Hepatitis B surface antigenemia at birth: a long-term follow-up study. J Pediatr. 133: 374-7.
Thimme R., Wieland S, Steiger C. 2003. CD8 T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection. Journal of Virology 77: 68–76. A. Thomas H.G, Lemon B, Zuchman A.J, editors. Viral Hepatitis: 2005. P. 50-64.
Thorgeirsson SS, Grisham JW. 2003. Overview of recent experimental studies on liver stem cells. Seminars in Liver Disease 23: 303–312.
Weber B. 2005. Genetic variability of the S gene of hepatitis B virus: clinical and diagnostic impact. J Clin Virol 32(2): 102-112.
WHO (2015) Hepatitis B. Fact sheet N° 204.
Wieland SF, Spangenber HC, Thimme R. 2004. Expansion and contraction of the hepatitis B virus transcriptional template in infected chimpanzees. Proceedings of the National Academy of Sciences of the United States of America 101: 2129–2134.
Wright TL, Lau JY. 1985. Clinical aspects of hepatitis B virus infection. Lancet 342:1340-4.
Xu ZY, Liu CB, Francis DP. 1985. Prevention of perinatal acquisition of hepatitis B virus carriage using vaccine: preliminary report of a randomized, double-blind placebo-controlled and comparative trial. Pediatrics 76:713-718.
Yotsuyanagi H, Yasuda K, Iino S, Moriya K, Shintani Y, Fujie H, Tsutsumi T, Kimura S, Koike K. 1998. Persistent viremia after recovery from self-limited acute hepatitis B. Hepatology 27: 1377- 1382.
Yu MW, Chang HC, Liaw YF. 2000. Familial risk of hepatocellular carcinoma among chronic hepatitis B carriers and their relatives. J Natl Cancer Inst 92: 1159-1164.
Yuki N, Nagaoka T, Yamashiro M, Mochizuki K, Kaneko A, Yamamoto K. 2003. Long-term histologic and virologic outcomes of acute self-limited hepatitis B. Hepatology 37: 1172 – 9.
Zhang Z, Torii N, Hu Z, Jacob J, Liang TJ. 2001. X-deficient woodchuck hepatitis virus mutants behave like attenuated viruses and induce protective immunity in vivo. J Clin Invest.108:1523–1531.